Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites
Nutrients · 31.12.2024 · 17 (1) · 155
DOI: 10.3390/nu17010155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.12.2024. Verfasst von María José García Mansilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Centro de investigación Biomédica (CIBM), University of Granada, 18071 Granada, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Irritable Bowel Syndrome, Probiotics. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junta de Andalucía (CTS 164).
Abstract (Originalsprache)
Irritable bowel syndrome is a common functional gastrointestinal disorder characterized by recurrent abdominal discomfort, bloating, cramping, flatulence, and changes in bowel movements. The pathophysiology of IBS involves a complex interaction between motor, sensory, microbiological, immunological, and psychological factors. Diversity, stability, and metabolic activity of the gut microbiota are frequently altered in IBS, thus leading to a situation of gut dysbiosis. Therefore, the use of probiotics and probiotic-derived metabolites may be helpful in balancing the gut microbiota and alleviating irritable bowel syndrome symptoms. This review aimed to report and consolidate recent progress in understanding the role of gut dysbiosis in the pathophysiology of IBS, as well as the current studies that have focused on the use of probiotics and their metabolites, providing a foundation for their potential beneficial effects as a complementary and alternative therapeutic strategy for this condition due to the current absence of effective and safe treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Centro de investigación Biomédica (CIBM), University of Granada, 18071 Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
- CIBER de Enfermedades Hepáticas y Digestivas (CIBER-EHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: María Jesús Rodríguez Sojo, Antonio Jesús Ruiz Malagón, Julio Gálvez, Alba Rodríguez Nogales, María José Rodríguez Sánchez
Förderung
- Junta de Andalucía (CTS 164)
Zitieren
APA
García Mansilla, M. J., Rodríguez Sojo, M. J., Lista, A. R., Ayala Mosqueda, C. V., Ruiz Malagón, A. J., Gálvez, J., Rodríguez Nogales, A., & Rodríguez Sánchez, M. J. (2024). Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites. Nutrients, 17(1), 155. https://doi.org/10.3390/nu17010155
Vancouver
García Mansilla MJ, Rodríguez Sojo MJ, Lista AR, Ayala Mosqueda CV, Ruiz Malagón AJ, Gálvez J, et al. Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites. Nutrients. 2024;17(1):155. doi:10.3390/nu17010155
BibTeX
@article{GarcaMansilla2024,
author = {García Mansilla, María José and Rodríguez Sojo, María Jesús and Lista, Andrea Roxana and Ayala Mosqueda, Ciskey Vanessa and Ruiz Malagón, Antonio Jesús and Gálvez, Julio and Rodríguez Nogales, Alba and Rodríguez Sánchez, María José},
title = {Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites},
journal = {Nutrients},
year = {2024},
volume = {17},
number = {1},
pages = {155},
doi = {10.3390/nu17010155}
}
EUVIMED